Joint (JYNT) Projected to Announce Quarterly Earnings on Thursday

Joint (NASDAQ:JYNT) is projected to post its Q2 2026 results after the market closes on Thursday, August 6th. Analysts expect the company to post earnings of $0.0467 per share and revenue of $14.5730 million for the quarter. Parties are encouraged to explore the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Thursday, August 6, 2026 at 5:00 PM ET.

Joint (NASDAQ:JYNT) last issued its earnings results on Thursday, May 7th. The company reported $0.08 EPS for the quarter, topping the consensus estimate of $0.03 by $0.05. Joint had a return on equity of 7.00% and a net margin of 5.72%.The company had revenue of $14.82 million during the quarter, compared to analyst estimates of $14.50 million. On average, analysts expect Joint to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Joint Trading Up 0.9%

Shares of NASDAQ JYNT opened at $8.28 on Wednesday. Joint has a twelve month low of $7.50 and a twelve month high of $11.26. The company has a market capitalization of $118.07 million, a price-to-earnings ratio of 36.00 and a beta of 1.10. The business has a 50 day simple moving average of $8.81 and a 200-day simple moving average of $8.90.

Insider Buying and Selling

In other Joint news, major shareholder Charles E. Jobson purchased 127,676 shares of the business’s stock in a transaction dated Tuesday, May 12th. The shares were bought at an average price of $8.57 per share, with a total value of $1,094,183.32. Following the completion of the acquisition, the insider owned 1,773,479 shares in the company, valued at approximately $15,198,715.03. This represents a 7.76% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 30.20% of the company’s stock.

Institutional Trading of Joint

Hedge funds and other institutional investors have recently modified their holdings of the company. JCP Investment Management LLC acquired a new position in Joint during the 2nd quarter worth $5,526,000. Russell Investments Group Ltd. lifted its position in Joint by 77.3% during the 4th quarter. Russell Investments Group Ltd. now owns 205,411 shares of the company’s stock worth $1,791,000 after buying an additional 89,526 shares in the last quarter. First Foundation Advisors lifted its holdings in Joint by 47.8% during the 3rd quarter. First Foundation Advisors now owns 273,759 shares of the company’s stock worth $2,612,000 after buying an additional 88,486 shares in the last quarter. Squarepoint Ops LLC bought a new stake in Joint during the 4th quarter worth about $766,000. Finally, Topline Capital Management LLC raised its position in shares of Joint by 18.7% during the 2nd quarter. Topline Capital Management LLC now owns 449,204 shares of the company’s stock valued at $5,184,000 after acquiring an additional 70,910 shares during the last quarter. Institutional investors own 76.88% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on JYNT shares. Weiss Ratings raised shares of Joint from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, June 12th. Zacks Research cut shares of Joint from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 7th. Finally, Wall Street Zen cut shares of Joint from a “strong-buy” rating to a “buy” rating in a report on Sunday, June 7th. Three investment analysts have rated the stock with a Hold rating, According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $18.00.

Joint Company Profile

The Joint Chiropractic, Inc, doing business as Joint (NASDAQ: JYNT), is a franchisor and operator of outpatient chiropractic clinics in the United States. Under its flagship The Joint Chiropractic brand, the company offers membership-based, cash-focused spinal adjustment services designed to promote accessible, routine care for neck and back discomfort. By removing insurance requirements and offering walk-in visits, Joint aims to streamline the patient experience and reduce cost barriers to ongoing chiropractic treatment.

Joint’s growth strategy centers on partnering with franchisees to expand its network of clinics.